{
    "organizations": [],
    "uuid": "fd45fd1cfdf90855fd6f84bf007eed10927f180e",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/02/28/globe-newswire-trevena-to-host-conference-call-on-march-7th-to-discuss-full-year-2017-financial-results.html",
    "ord_in_thread": 0,
    "title": "Trevena to Host Conference Call on March 7th to Discuss Full Year Financial Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for the quarter and year ended December 31, 2017 and to discuss recent corporate highlights.\nTo join the call, please dial-in at (855) 465-0180 (conference ID: 7843918).\nTo join a live audio webcast of the call, please visit the Investor Presentation section of the Company’s website (conference ID: 7843918). Following the conclusion of the call, the webcast will be available for replay for 30 days.\nAbout Trevena\nTrevena, Inc. is a biopharmaceutical company focused on providing better, safer therapies to patients in pain. The Company has leveraged breakthrough science to discover and develop its investigational product OLINVO™ (oliceridine) Injection for the management of moderate-to-severe acute pain. The Company also has an early stage pipeline of new chemical entities targeting novel mechanisms of action, including for acute migraine, neuropathic pain, and other indications.\nContacts\nTrevena, Inc.\nInvestors:\nJonathan Violin, Ph.D.\nSVP, scientific affairs and investor relations officer\n610-354-8840 x231\njviolin@trevena.com\nor\nMedia:\nPublic Relations\nPR@trevena.com\nSource:Trevena Inc.",
    "published": "2018-02-28T15:00:00.000+02:00",
    "crawled": "2018-02-28T17:12:25.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "chesterbrook",
        "globe",
        "newswire",
        "trevena",
        "nasdaq",
        "trvn",
        "today",
        "announced",
        "host",
        "conference",
        "call",
        "wednesday",
        "march",
        "est",
        "review",
        "financial",
        "result",
        "quarter",
        "year",
        "ended",
        "december",
        "discus",
        "recent",
        "corporate",
        "highlight",
        "join",
        "call",
        "please",
        "conference",
        "id",
        "join",
        "live",
        "audio",
        "webcast",
        "call",
        "please",
        "visit",
        "investor",
        "presentation",
        "section",
        "company",
        "website",
        "conference",
        "id",
        "following",
        "conclusion",
        "call",
        "webcast",
        "available",
        "replay",
        "day",
        "trevena",
        "trevena",
        "biopharmaceutical",
        "company",
        "focused",
        "providing",
        "better",
        "safer",
        "therapy",
        "patient",
        "pain",
        "company",
        "leveraged",
        "breakthrough",
        "science",
        "discover",
        "develop",
        "investigational",
        "product",
        "oliceridine",
        "injection",
        "management",
        "acute",
        "pain",
        "company",
        "also",
        "early",
        "stage",
        "pipeline",
        "new",
        "chemical",
        "entity",
        "targeting",
        "novel",
        "mechanism",
        "action",
        "including",
        "acute",
        "migraine",
        "neuropathic",
        "pain",
        "indication",
        "contact",
        "trevena",
        "investor",
        "jonathan",
        "violin",
        "svp",
        "scientific",
        "affair",
        "investor",
        "relation",
        "officer",
        "x231",
        "jviolin",
        "medium",
        "public",
        "relation",
        "pr",
        "source",
        "trevena",
        "inc"
    ]
}